New paper on novel human gut-derived LEAP2 fragment

Identification and metabolic profiling of a novel human gut-derived LEAP2 fragment.
Congratulations to
Christoffer Hagemann
for getting this comprehensive study published in Journal of Clinical Endocrinology (JCEM)! The study was kickstarted by
Tina Jorsal
and good friends from
Gubra
(Jacob Jelsing, Niels Vrang and Kristoffer Rigbolt) with support from Sanofi scientists back in 2014.
A huge thanks to all contributors!
Read the full paper on JCEM
Redaktør